“`html
Insulet Corporation (PODD) reported third-quarter 2025 earnings per share (EPS) of $1.24, marking a 37.8% year-over-year increase and exceeding the Zacks Consensus Estimate by 9.73%. Total revenues reached $706.3 million, surpassing expectations by 4.42% and showing a 29.9% increase compared to the same quarter last year.
Within the segment, Omnipod revenues totaled $699.2 million, a 31% rise year-over-year. U.S. revenues were $497.1 million (up 25.6%), while international revenues reached $202.1 million (up 46.5%). Insulet’s gross profit for the quarter was $510.1 million, reflecting a gross margin of 72.2%. The company ended the quarter with cash and cash equivalents of $757.4 million.
For the full year, Insulet anticipates revenue growth of 28%-29% at constant exchange rates, adjusting its forecast upward from a previous range of 24%-27%. For Q4, they project a revenue increase of 25%-28%.
“`
